Bortezomib, Bendamustine and Dexamethasone vs Thalidomide, Bendamustine and Dexamethasone in Myeloma patients presenting with renal failure (OPTIMAL): a randomised, multi-centre phase II trial

• Karthik Ramasamy,
• Gulnaz Iqbal,
• Richard Brouwer,
• Victoria Stalker,
• Salma Akhtar,
• Sherin Varghese,
• Jindriska Lindsay,
• Stephen Schey,
• Mark Drayson,
• Janet Dunn

Affiliations

Karthik Ramasamy

Churchill Hospital, Oxford University Hospitals NHS Foundation Trust

Gulnaz Iqbal

Warwick Clinical Trials Unit, University of Warwick

Richard Brouwer

Churchill Hospital, Oxford University Hospitals NHS Foundation Trust

Victoria Stalker

Churchill Hospital, Oxford University Hospitals NHS Foundation Trust

Salma Akhtar

Churchill Hospital, Oxford University Hospitals NHS Foundation Trust

Sherin Varghese

Churchill Hospital, Oxford University Hospitals NHS Foundation Trust

Jindriska Lindsay

East Kent Hospitals University Trust

Stephen Schey

King’s College Hospital NHS Foundation Trust

Mark Drayson

Division of Immunity & Immunotherapy, University of Birmingham

Janet Dunn

Warwick Clinical Trials Unit, University of Warwick